| Control | DNG | p |
---|---|---|---|
Patients (n) | 34 | 30 | Â |
Age (years) | 33.6 ± 3.6 | 34.2 ± 3.4 | ns |
Stage of endometriosis rASRM (III) | 9 | 10 | Â |
rASRM (IV) | 5 | 6 | Â |
Serum CA125 (U/ml) (before DNG) | – | 44.2 ± 35.3 |  |
Serum CA125 (U/ml) | 26.4 ± 16.8 | 29.1 ± 26.9 | ns |
Gonadotropin (FSH/HMG) dose (IU) | 1304 ± 338 | 1553 ± 528 | P < 0.05 |
Estradiol (pg/ml) | 1731 ± 958 | 1288 ± 1091 | P < 0.05 |
Progesterone (ng/ml) | 1.11 ± 1.14 | 1.72 ± 2.0 | ns |
Follicles ≥15 mm (n) | 6.5 ± 4.2 | 4.6 ± 3.2 | P < 0.05 |